NDC 57894-160
INFLIXIMAB
Infliximab
INFLIXIMAB is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is Infliximab.
| Product ID | 57894-160_5b95c131-42b2-4cda-bd00-101b93199f95 |
| NDC | 57894-160 |
| Product Type | Human Prescription Drug |
| Proprietary Name | INFLIXIMAB |
| Generic Name | Infliximab |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-10-05 |
| Marketing Category | BLA / |
| Application Number | BLA103772 |
| Labeler Name | Janssen Biotech, Inc. |
| Substance Name | INFLIXIMAB |
| Active Ingredient Strength | 100 mg/10mL |
| Pharm Classes | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |